Study details
Enrolling now
Magnetic Seizure Therapy for Depression
Joao L. DeQuevedo
NCT IDNCT04080778ClinicalTrials.gov data as of Apr 2026
Target enrollment
60
Study length
about 3.4 years
Ages
22–85
Locations
1 site in TX
About this study
Researchers are testing whether magnetic seizure therapy (MST) or electroconvulsive therapy (ECT) can help people with bipolar depression or treatment-resistant depression. The trial will last about 12 months and involve around 60 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use electroconvulsive therapy (ECT)
- 2.Use magnetic seizure therapy (MST)
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low14%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Change in cognitive impairment as measured by the Montreal Cognitive Assessment (MoCA)
Body systems
Psychiatry / Mental Health